Haematopoietic Stem Cells

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/87

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

88 Terms

1
New cards

What are the most studied adult stem cells?

HSCs

2
New cards

How many nucleated cells are in the human bone marrow?

1×10^12

3
New cards

How many active HSCs are within the adult bone marrow?

50,000-200,000 (1/10million nucleated cells)

4
New cards

How often do HSCs divide?

Once every 40 weeks?

5
New cards

What is the key characteristic of HSCs?

They produce progenitors that provide every cell in the blood system.

6
New cards

What is haematopoeisis?

The production of haematopoietic blood cells.

7
New cards

What is the rate of blood cell production?

4-5×10^11 cells a day (HSCs divide rarely but proliferation of daughter cells).

8
New cards

What do HSCs give rise to?

Myeloid & lymphoid progenitors.

9
New cards

Where does haematopoiesis occur in prenatal stages?

Yolk sac and liver.

10
New cards

Where does haematopoiesis occur in postnatal stages?

Vertebrae and pelvis and sternum.

11
New cards

Where does haematopoiesis occur around birth?

Bone marrow, femur and tibia.

12
New cards

What is the process where fat replaces haematopoietic marrow in long bones?

Marrow involution.

13
New cards

How has our understanding of the haematopoietic differentiation hierarchy evolved from 2000-now?

2000: stepwise hierarchy with distinct myeloid and lymphoid branches, 2005-16: heterogeneity in the HSC pool with multipotent progenitors, now: continuous differentiation model with overlapping fates.

14
New cards

What is the current view of haematopoietic differentiation?

A continuum model with lineage-based HSCs, fate decision occur early and more gradually with early transcriptional priming toward specific lineages (less hierarchical and more dynamic).

15
New cards

What is the history of HSC research?

Radiation damage from atomic bomb testing let to bone marrow transplant research that let to the discovery of HSCs.

16
New cards

What are 6 characteristics of HSCs that make them well studied?

Tissue accessibility and ease of sampling (bone marrow aspirate and peripheral blood), soft tissue properties with high cellularity and easy to disaggregate), morphologically distinct making them easy to identify when stained, robust in vivo reconstitution assays, straightforward delivery of cells (tail-vein infusion of direct BM injection), can do lineage tracing in vivo to track fate and developmental potential.

17
New cards

What is the basic test of reconstitution?

Give mouse a sublethal/lethal dose of ionising radiation to wipe out existing system. Intravenous injection of HSCs causes recovery as cells home to BM and produce new blood cells. Otherwise mouse dies.

18
New cards

What are long-term HSCs?

Self-renew over lifespan with the ability to differentiation into all types of blood cells (maintains whole HSC system). They divide infrequently to maintain quiescence and preserve regenerative capacity.

19
New cards

What are short-term HSCs?

Limited self-renewal capacity and more involved in progenitor cells. Contribute to haematopoiesis for weeks/months and provide an immediate response to the body’s need for new blood cells (infection etc).

20
New cards

What is the main marker for HSCs?

CD34+

21
New cards

What are the cell-surface markers for LT-HSCs?

Lin-CD34+CD38-CD45RA-CD49f+CD90+ ±Rholo

22
New cards

What are the cell-surface markers for ST-HSCs?

Lin-C34+CD38-CD45RA-CD49f-CD90+

23
New cards

What is rho (rhodamine 123)?

Membrane dye for mitochondria (indicator of mitochondrial membrane potential).

24
New cards

Why should cells be enriched?

For therapeutic use or further study.

25
New cards

What regulates HSC differentiation and lineage commitment?

Cytokines, growth factors, signalling from the niche.

26
New cards

Give an example of cytokines/growth factors important for differentiation.

IL-7 for common lymphoid progenitor cells, and IL-3/GM-CSF/M-CSF for common myeloid progenitor cells.

27
New cards

Explain the stem cell niche.

All forces/interactions acting on the cells influence cell fate. Different parts of the body and within tissues have different signalling.

28
New cards

Give 3 examples of different interactions within the niche.

Physical signals from ECM components, soluble signals from cytokines/chemokines, cell-cell interactions through cadherins.

29
New cards

How can you identify each lineage of HSC?

Marker combinations using flow cytometry.

30
New cards

What are the 4 cell fate processes?

Quiescence, proliferation, maintenance, retention.

31
New cards

Explain quiescence.

Dormancy to prevent exhaustion and maintain long-term regenerative capacity.

32
New cards

Explain proliferation.

Division to produce stem cells and differentiated cells that is important for injury/infection.

33
New cards

Explain maintenance.

Preservation of the HSC pool involving mechanisms that balance quiescence/proliferation, DDR, and protect cells from stress/ageing.

34
New cards

Explain retention.

Mechanisms that keep HSCs in their niche important for correct function and stability.

35
New cards

Why can change the balance of fate determination in the niche?

Changes to signalling.

36
New cards

Where is the HSC niche?

In close proximity (within 10um) to sinusoids in red bone marrow.

37
New cards

What is yellow bone marrow?

Adipocytes and MSCs (increases in long bones as we age).

38
New cards

Why have transgenic mice been helpful in HSC studies?

Helped us to determine the HSC niche through similarities between haematopoietic systems.

39
New cards

What are the drawbacks of using transgenic mice in HSC studies?

Very different anatomy and long bones of mice contribute to haematopoiesis greater than those of humans.

40
New cards

Why has the identification of the HSC niche been difficult?

The rarity of HSCs in the high cellular content of bone marrow.

41
New cards

What techniques enabled the identification of the HSC niche?

Marker identification and imaging techniques (such as optical clearing of bones to overcome opacity, reduce light scattering and enable deeper imaging with microscopy).

42
New cards

What identifies HSCs from other cellular cells in the bone marrow in imaging studies?

Co-expression of c-Kit and ACAT-GFP, and round morphology.

43
New cards

What is c-Kit?

Receptor tyrosine kinase highly expressed on HSCs critical for survival, proliferation and maintenance.

44
New cards

What is Acat-GFP?

Acetyl-coA acetyltransferase involved in lipid metabolism that labels the unique metabolic profile of HSCs when fused to GFP.

45
New cards

What is the sinusoid?

Large continuous blood vessels that span the bone marrow.

46
New cards

Where are non-dividing HSCs enriched?

Central marrow (20%).

47
New cards

Where are dividing HSCs enriched?

Endosteal region (80%).

48
New cards

Where do implanted HSCs home to/reconstitution happen?

Endosteal region.

49
New cards

What intrinsic factors determines the fate of HSCs (cell-cycle entry or quiescence)?

Transcription factors, cell cycle regulators, epigenetic landscape.

50
New cards

What external factors trigger cell-cycle entry opposed to quiescence?

ROA, hypoxia, SCF (kit factor)

51
New cards

What does symmetric division achieve?

Expansion (HSC + HSC) or differentiation (HPC + HPC)

52
New cards

What does asymmetric division achieve?

Maintenance (HSC+ HPC)

53
New cards

What promotes maintainence in the HSC niche?

Leptin receptor (Lepr+) perivascular stromal cells, endothelial cells and NG2+ pericytes secrete maintainence factors.

54
New cards

What factors secreted by cells in the niche promote maintenance?

CXCL12 and SCF

55
New cards

What enables HSC mobilisation (BM —> blood)?

Circadian release of noradrenaline that downregulates CXCL12, and secretion of granulocyte-colony stimulating factor.

56
New cards

What factors promote quiescence in the HSC niche?

TGFbeta and CXCL4

57
New cards

What factors promote proliferation in the niche?

Notch ligands (jagged-1) and thrombopoietin.

58
New cards

What factors promote retention in the niche?

Pleiotrophin, CXCL12

59
New cards

What percentage of HSCs are perivascular?

80%

60
New cards

When tracking HSCs in live mice using microscopy, are LT-HSC or MPP closer to the endosteum?

LT-HSC

61
New cards

Where are MPPs located?

50/50 split between transitional zone vessels and sinusoids (migrated in relation to the parent HSCs).

62
New cards

Do HSCs exist in a hypoxic environment?

No, the oxygen concentration in LT-HSCs and MPPs is basically the same as the extracellular space around the blood vessels (normal concentration you find in tissue).

63
New cards

Are LT-HSCs or MPPs more motile (higher displacement)?

MPPs

64
New cards

How can you stimulate LT-HSCs to move?

Cyclophosphamide and granulocyte colony stimulating factor but depends on the environment they are in.

65
New cards

What type of of bone are LT-HSCs most motile in?

Mixed-type

66
New cards

What type of bone are MPPs most motile in?

Mixed and resorption type.

67
New cards

How are different bone types created?

From the different extents of bone remodelling.

68
New cards

What is resorption type bone?

Bone tissue is broken down and new bone is deposited.

69
New cards

What is deposition type bone?

The bone tissue is not broken, new bone is deposited on top of the existing bone.

70
New cards

What is associated with ageing?

Reduced DDR (GIN), ROS accumulation, epigenetic drift (change in DNA methylation patterns).

71
New cards

Do young or old HSCs have a good balance of myeloid and lymphoid progenitors?

Young.

72
New cards

What happens in older HSCs?

Clonal expansion and greater proliferation in certain cells resulting in an imbalanced proportion of myeloid and lymphoid progenitor cells. Reduced lymphoid cells results in weaker immune system and increased myeloid cells increases risk of malignancies.

73
New cards

What is the role of osteopontin?

Negative regulator of proliferation.

74
New cards

What is the role of adipocytes?

Downregulates proliferation.

75
New cards

Role of adipocytes in ageing.

More fat in older tissue, adds more of a brake to proliferation

76
New cards

Why does age increase the risk of malignancies?

Bone loss decreases the level of osteopontin which increases proliferation.

77
New cards

How does age affect the niche?

Reduced CXCL12/SCF, reduced Jagged (less notch signalling), reduced adrenergic nerve fibres (less mobilisation into blood)

78
New cards

What is the phenomenon caused by ageing?

Clonal haematopoiesis of indeterminate potential (CHIP).

79
New cards

How many protein coding mutations exist in the elderly HSC pool?

350,000-1.4million

80
New cards

Does CHIP affect other things than blood cancer?

Yes, coronary heart disease (1.8 increased hazard ratio)l

81
New cards

What is the only established stem cell therapy?

HSC (bone marrow) transplant.

82
New cards

What is myeloablative conditioning?

Total body irradiation and/or chemotherapeutics at high doses which don’t recover the haematopoietic system.

83
New cards

What can HSC transplantation treat?

Mostly leukaemia like AML, CML and ALL, but also immune disorders (SCID) and blood disorders (sickle cell anaemia).

84
New cards

Explain how autologous HSC transplants for blood cancers work.

Pretreatment with G-CSF to mobilise HSCs to peripheral blood and G-PBMCs are collected from blood or bone marrow. HSCs are selected based on their markers and frozen. Patient gets irradiated to kill remaining cancer cells and any remains HSCs. Frozen HSCs are infused back, home to the bone marrow and produce new blood cells.

85
New cards

What is the limitation of autologous HSC transplantation?

High risk of infection and GvHD.

86
New cards

What is graft vs host disease?

Transplanted donor cells recognise the recipients tissues/cells as foreign and attack them, mostly affecting the skin, liver and GI tract.

87
New cards

How to avoid GvHD?

Enrich for CD34+ cells from G-PBMC as it reduces the number of immune cells in transplant graft.

88
New cards

How can HSC transplants treat other conditions?

Defective HSCs can be corrected with gene editing and reconstitute the haematopoietic system without the defect.